Built at the Internet Archive
Date
Sort By:
Sites for this collection are listed below. Narrow your results at left, or enter a search query below to find a site, specific URL or to search the text of archived webpages.
Page 1 of 1 (4 Total Results)
Sort By:
Description: Johnson & Johnson (NYSE: JNJ) (the Company) has entered into an agreement with the U.S. Government and Gavi, the Vaccine Alliance (Gavi), to enable access to its single-shot COVID-19 vaccine through a novel mechanism – the COVAX Humanitarian Buffer – that will serve to protect the world's most vulnerable people.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Vaccines, Gavi, the Vaccine Alliance, COVAX Humanitarian Buffer, conflict zones, Humanitarianism
Creator: Johnson & Johnson
Publisher: PRNewswire
Source: https://finance.yahoo.com
Language: English
Format: online newspaper
Type: article
Date: November 10, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson, COVID-19, Vaccines, Food and Drug Administration
Creator: Johnson & Johnson
Publisher: Johnson & Johnson
Source: www.jnj.com
Language: English
Format: website
Type: article
Date: February 27, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced the completion of a landmark agreement between Janssen Pharmaceuticals, Inc., and manufacturer Aspen SA Operations (Pty) Ltd, based in South Africa, to enable the first COVID-19 vaccine to be manufactured and made available by an African company for people living in Africa, with the goal of increasing COVID-19 vaccination rates across the continent.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID, Johnson & Johnson, Vaccine, Africa
Creator: Johnson & Johnson
Publisher: News Journal
Source: www.news-journal.com
Language: English
Format: online newspaper
Type: article
Date: March 8, 2022
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19, Vaccines, Johnson & Johnson
Creator: Johnson & Johnson
Publisher: PRnewswire.com
Source: www.prnewswire.com
Language: English
Coverage: New Brunswick, NJ
Format: online newspaper
Type: article
Date: October 8, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Page 1 of 1 (4 Total Results)
